Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa

Gualtiero Colombo, Roberto Buffa, Maria Teresa Bardella, Letizia Garofalo, Andrea Carlin, James M. Lipton, Anna Catania

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: The peptide α-melanocyte-stimulating hormone (α-MSH) possesses potent anti-inflammatory activities and has been previously implicated in the endogenous control of inflammatory reactions. The aim of the present research was to determine whether α-MSH and its receptors participate in a localized anti-inflammatory response in the duodenal mucosa of celiac patients. Methods: Three series of experiments were performed, using duodenal biopsy pairs from 53 adult celiac patients and 14 normal subjects, in order to determine: (1) mucosal immunoreactivity for α-MSH and melanocortin receptors (MCRs), and gene expression of α-MSH precursor pro-opiomelanocortin and MCRs; (2) α-MSH and inflammatory cytokine production by duodenal specimens in vitro, and the influence of synthetic α-MSH on such cytokine production, and (3) the influence of stimulation with gliadin (the subfraction of gluten that is toxic to patients with celiac disease) on α-MSH and cytokine production in vitro and the effect of α-MSH on gliadin-stimulated cytokine production. Results: Elements of a localized anti-inflammatory influence based on α-MSH and its receptors were found: duodenal mucosa showed immunostaining for α-MSH and two of its receptor subtypes, MC1R and MC5R. α-MSH and MC1R immunoreactivity was more intense in specimens from celiac patients. Release of interleukin 6 from gliadin-stimulated duodenal mucosa was inhibited by synthetic α-MSH in vitro. Conclusions: Presence of α-MSH and its receptors in celiac mucosa suggests the presence of a local reaction to control the inflammatory response elicited by gliadin. In selected cases of refractory celiac disease, treatment with exogenous peptides might be considered.

Original languageEnglish
Pages (from-to)208-216
Number of pages9
JournalNeuroImmunoModulation
Volume10
Issue number4
DOIs
Publication statusPublished - 2002

Fingerprint

Melanocyte-Stimulating Hormones
Intestinal Mucosa
Abdomen
Anti-Inflammatory Agents
Gliadin
Mucous Membrane
Melanocortin Receptors
Cytokines
Celiac Disease
Pro-Opiomelanocortin
Peptides
Glutens
Poisons
Interleukin-6
Biopsy
Gene Expression

Keywords

  • α-Melanocyte stimulating hormone
  • Celiac disease
  • Duodenal mucosa
  • Gliadin
  • Interleukin-6
  • Melanocortin receptors

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Immunology

Cite this

Colombo, G., Buffa, R., Bardella, M. T., Garofalo, L., Carlin, A., Lipton, J. M., & Catania, A. (2002). Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa. NeuroImmunoModulation, 10(4), 208-216. https://doi.org/10.1159/000068323

Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa. / Colombo, Gualtiero; Buffa, Roberto; Bardella, Maria Teresa; Garofalo, Letizia; Carlin, Andrea; Lipton, James M.; Catania, Anna.

In: NeuroImmunoModulation, Vol. 10, No. 4, 2002, p. 208-216.

Research output: Contribution to journalArticle

Colombo, G, Buffa, R, Bardella, MT, Garofalo, L, Carlin, A, Lipton, JM & Catania, A 2002, 'Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa', NeuroImmunoModulation, vol. 10, no. 4, pp. 208-216. https://doi.org/10.1159/000068323
Colombo, Gualtiero ; Buffa, Roberto ; Bardella, Maria Teresa ; Garofalo, Letizia ; Carlin, Andrea ; Lipton, James M. ; Catania, Anna. / Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa. In: NeuroImmunoModulation. 2002 ; Vol. 10, No. 4. pp. 208-216.
@article{6dceb06ae37947fcbb118b5b62c64908,
title = "Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa",
abstract = "Objectives: The peptide α-melanocyte-stimulating hormone (α-MSH) possesses potent anti-inflammatory activities and has been previously implicated in the endogenous control of inflammatory reactions. The aim of the present research was to determine whether α-MSH and its receptors participate in a localized anti-inflammatory response in the duodenal mucosa of celiac patients. Methods: Three series of experiments were performed, using duodenal biopsy pairs from 53 adult celiac patients and 14 normal subjects, in order to determine: (1) mucosal immunoreactivity for α-MSH and melanocortin receptors (MCRs), and gene expression of α-MSH precursor pro-opiomelanocortin and MCRs; (2) α-MSH and inflammatory cytokine production by duodenal specimens in vitro, and the influence of synthetic α-MSH on such cytokine production, and (3) the influence of stimulation with gliadin (the subfraction of gluten that is toxic to patients with celiac disease) on α-MSH and cytokine production in vitro and the effect of α-MSH on gliadin-stimulated cytokine production. Results: Elements of a localized anti-inflammatory influence based on α-MSH and its receptors were found: duodenal mucosa showed immunostaining for α-MSH and two of its receptor subtypes, MC1R and MC5R. α-MSH and MC1R immunoreactivity was more intense in specimens from celiac patients. Release of interleukin 6 from gliadin-stimulated duodenal mucosa was inhibited by synthetic α-MSH in vitro. Conclusions: Presence of α-MSH and its receptors in celiac mucosa suggests the presence of a local reaction to control the inflammatory response elicited by gliadin. In selected cases of refractory celiac disease, treatment with exogenous peptides might be considered.",
keywords = "α-Melanocyte stimulating hormone, Celiac disease, Duodenal mucosa, Gliadin, Interleukin-6, Melanocortin receptors",
author = "Gualtiero Colombo and Roberto Buffa and Bardella, {Maria Teresa} and Letizia Garofalo and Andrea Carlin and Lipton, {James M.} and Anna Catania",
year = "2002",
doi = "10.1159/000068323",
language = "English",
volume = "10",
pages = "208--216",
journal = "NeuroImmunoModulation",
issn = "1021-7401",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa

AU - Colombo, Gualtiero

AU - Buffa, Roberto

AU - Bardella, Maria Teresa

AU - Garofalo, Letizia

AU - Carlin, Andrea

AU - Lipton, James M.

AU - Catania, Anna

PY - 2002

Y1 - 2002

N2 - Objectives: The peptide α-melanocyte-stimulating hormone (α-MSH) possesses potent anti-inflammatory activities and has been previously implicated in the endogenous control of inflammatory reactions. The aim of the present research was to determine whether α-MSH and its receptors participate in a localized anti-inflammatory response in the duodenal mucosa of celiac patients. Methods: Three series of experiments were performed, using duodenal biopsy pairs from 53 adult celiac patients and 14 normal subjects, in order to determine: (1) mucosal immunoreactivity for α-MSH and melanocortin receptors (MCRs), and gene expression of α-MSH precursor pro-opiomelanocortin and MCRs; (2) α-MSH and inflammatory cytokine production by duodenal specimens in vitro, and the influence of synthetic α-MSH on such cytokine production, and (3) the influence of stimulation with gliadin (the subfraction of gluten that is toxic to patients with celiac disease) on α-MSH and cytokine production in vitro and the effect of α-MSH on gliadin-stimulated cytokine production. Results: Elements of a localized anti-inflammatory influence based on α-MSH and its receptors were found: duodenal mucosa showed immunostaining for α-MSH and two of its receptor subtypes, MC1R and MC5R. α-MSH and MC1R immunoreactivity was more intense in specimens from celiac patients. Release of interleukin 6 from gliadin-stimulated duodenal mucosa was inhibited by synthetic α-MSH in vitro. Conclusions: Presence of α-MSH and its receptors in celiac mucosa suggests the presence of a local reaction to control the inflammatory response elicited by gliadin. In selected cases of refractory celiac disease, treatment with exogenous peptides might be considered.

AB - Objectives: The peptide α-melanocyte-stimulating hormone (α-MSH) possesses potent anti-inflammatory activities and has been previously implicated in the endogenous control of inflammatory reactions. The aim of the present research was to determine whether α-MSH and its receptors participate in a localized anti-inflammatory response in the duodenal mucosa of celiac patients. Methods: Three series of experiments were performed, using duodenal biopsy pairs from 53 adult celiac patients and 14 normal subjects, in order to determine: (1) mucosal immunoreactivity for α-MSH and melanocortin receptors (MCRs), and gene expression of α-MSH precursor pro-opiomelanocortin and MCRs; (2) α-MSH and inflammatory cytokine production by duodenal specimens in vitro, and the influence of synthetic α-MSH on such cytokine production, and (3) the influence of stimulation with gliadin (the subfraction of gluten that is toxic to patients with celiac disease) on α-MSH and cytokine production in vitro and the effect of α-MSH on gliadin-stimulated cytokine production. Results: Elements of a localized anti-inflammatory influence based on α-MSH and its receptors were found: duodenal mucosa showed immunostaining for α-MSH and two of its receptor subtypes, MC1R and MC5R. α-MSH and MC1R immunoreactivity was more intense in specimens from celiac patients. Release of interleukin 6 from gliadin-stimulated duodenal mucosa was inhibited by synthetic α-MSH in vitro. Conclusions: Presence of α-MSH and its receptors in celiac mucosa suggests the presence of a local reaction to control the inflammatory response elicited by gliadin. In selected cases of refractory celiac disease, treatment with exogenous peptides might be considered.

KW - α-Melanocyte stimulating hormone

KW - Celiac disease

KW - Duodenal mucosa

KW - Gliadin

KW - Interleukin-6

KW - Melanocortin receptors

UR - http://www.scopus.com/inward/record.url?scp=12244308531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244308531&partnerID=8YFLogxK

U2 - 10.1159/000068323

DO - 10.1159/000068323

M3 - Article

VL - 10

SP - 208

EP - 216

JO - NeuroImmunoModulation

JF - NeuroImmunoModulation

SN - 1021-7401

IS - 4

ER -